Why prohibit study drugs?

References

• Aikins, R.D. (2011). Academic performance enhancement: a qualitative study of the perceptions and habits of prescription stimulant-using college students. Journal of College Student Development, 52, 560–576. doi:10.1353/csd.2011.0064
   Web of Science ®Google Scholar
• Anderson, S. (2017). Coercion. In E.N. Zalta (Ed.), The Stanford encyclopedia of philosophy (Winter 2017 Edition). Stanford, CA: Metaphysics Research Lab, Stanford University. Retrieved from https://plato.stanford.edu/archives/win2017/entries/coercion/
   Google Scholar
• Bostrom, N., & Roache, R. (2007). Human enhancement: Ethical issues in human enhancement. In J. Ryberg, T.S. Petersen and C. Wolf (Eds.), New ways in applied ethics (pp. 120–152). Palgrave Macmillan, University of Michigan.
   Google Scholar
• Bostrom, N., & Sandberg, A. (2009). Cognitive enhancement: Methods, ethics, regulatory challenges. Science and Engineering Ethics, 15, 311–341. doi:10.1007/s11948-009-9142-5
   PubMed Web of Science ®Google Scholar
• Buchannan, A. (2011). Cognitive enhancement and education. Theory and Research in Education, 9, 2. doi:10.1177/1477878511409623
   Google Scholar
• Connecticut General Statutes Series 4000. Personnel (2012). Prohibition on recommendations for psychotropic An Act concerning Special Education. 34 C.F.R. § 300.174 Prohibition on mandatory medicalizationdrugs. § 10–212b. Public Act 06-18. Retrieved from https://www.cga.ct.gov/2015/act/pa/pdf/2015PA-00141-R00SB-00927-PA.pdf
   Google Scholar
• Controlled Substances Act (CSA): attended August 27, 2018. Title 21, United States Code. Retrieved from https://www.deadiversion.usdoj.gov/21cfr/21usc/844.htm
   Google Scholar
• DeSantis, A.D., & Hane, A.C. (2010). ;Adderall is definitely not a drug: Justifications for the illegal use of ADHD stimulants. Substance Use and Misuse, 45, 31–46. doi:10.3109/10826080902858334
   PubMed Web of Science ®Google Scholar
• Elliot, C. (2003). Better than well - American medicine meets the American dream. New York and London: W.W. Norton and Company.
   Google Scholar
• Farah, M.J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., ... Wolpe, P.R. (2004). Neurocognitive enhancement: what can we do and what should we do? Nature Reviews Neuroscience, 5, 421.
   Google Scholar
• Fitz, N.S., Nadler, R., Manogaran, P., Chong, E.W.J., & Reiner, P.B. (2014). Public attitudes toward cognitive enhancement. Neuroethics, 7, 173–188. doi:10.1007/s12152-013-9190-z
   Web of Science ®Google Scholar
• Forlini, C., & Racine, E. (2009). Autonomy and Coercion in academic "cognitive enhancement "using methylphenidate: Perspectives of key stakeholders. Neuroethics, 2, 163–177. doi:10.1007/s12152-009-9043-y
   Web of Science ®Google Scholar
• Forlini, C., & Racine, E. (2012). added stakeholders, added value(s) to the cognitive enhancement debate: Are academic discourse and professional policies sidestepping values of stakeholdesr? AJOB Primary Research, 3, 33–47. doi:10.1080/21507716.2011.645116
   Google Scholar
• Fukuyama, F. (2004). Transhumanism. Foreign Policy, 144, 42–43. doi:10.2307/4152980
   Google Scholar
• Glannon, W. (2011). Brain, body, and mind. Oxford – New York, NY: Oxford & New York, NY: Oxford University Press.
   Google Scholar
• Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P., & Farah, M.J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702–705. doi:10.1038/456702a
   PubMed Web of Science ®Google Scholar
• Inciardi, J.A., Surratt, H.L., Cicero, T.J., Kurtz, S.P., Martin, S.S., & Parrino, M.W. (2009). The "black box" of prescription drug diversion. Journal of Addictive Diseases, 28, 332–347. doi:10.1080/10550880903182986
   PubMed Web of Science ®Google Scholar
• Kass, L.R. (1985). Toward a more natural science. New York: The Free Press.
   Google Scholar
• McCabe, S.E., West, B.T., Teter, C.J., & Boyd, C.J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39, 1176–1182. doi:10.1016/j.addbeh.2014.03.008
   PubMed Web of Science ®Google Scholar
• Metzinger, T., & Hildt, E. (2011). Cognitive enhancement. In J. Illes & B J. Sahakian (Eds.), The oxford handbook of neuroethics (pp. 245–264). Oxford & New York, NY: Oxford University Press.
   Google Scholar
• Morein-Zamir, S., & Sahakian, B.J. (2011). Pharmaceutical cognitive enhancement. In J. Illes & B. J. Sahakian (Eds.), The oxford handbook of neuroethics (pp. 229–244). Oxford & New York, NY: Oxford University Press.
   Google Scholar
• Nozick, R. (1969). Coercion. In S. Morgenbesser, P. Suppes, & M. White (Eds.). Philosophy, science, and method: Essays in honor of Ernest Nagel (pp. 440–472). New York: St. Martin’s Press.
   Google Scholar
• Petersen, A. (2016). Praestationssamfundet. Denmark: Hans Reitzels Forlag.
   Google Scholar
• Petersen, M.A. (2018). Study drugs som vennetjeneste, ordineret medicin eller stoffer til salg. Tidsskrift for sygdom og samfund. Århus: Århus Universitet.
   Google Scholar
• Petersen, M.A. (2015). Governing Ambiguities - The Use of Prescription Stimulants Among University Students in New York City. PhD thesis: University of Copenhagen.
   Google Scholar
• Petersen, M.A., Nørgaard, L.S., & Traulsen, J.M. (2015a). Going to the doctor with enhancement in mind - an ethnographic study of university students' use of prescription stimulants and their moral ambivalence. Drugs: Education, Prevention, and Policy 22, 201–207. doi:10.3109/09687637.2014.970517
   Web of Science ®Google Scholar
• Petersen, M.A., Nørgaard, L.S., & Traulsen, J. (2015b). Pursuing pleasures of productivity: university students' use of prescription stimulants for enhancement and the moral uncertainty of making work fun. Culture, Medicine and Psychiatry, 39, 665–679. doi:10.1007/s11013-015-9457-4
   PubMed Web of Science ®Google Scholar
• Petersen, T.S. (2018). Should the state prohibit healthy people’s access to pharmacological cognitive enhancers? On arguments from coercion and individualization. International Journal of Law and Psychiatry. Advance online publication. doi:10.1016/j.ijlp.2018.07.010
   PubMedGoogle Scholar
• Ray, K.S. (2016). Not just “study drugs” for the rich: Stimulants as moral tools for creating opportunities for socially disadvantaged students. The American Journal of Bioethics, 16, 29–38. doi:10.1080/15265161.2016.1170231
   PubMed Web of Science ®Google Scholar
• Rosa, H. (2013). Alienation and acceleration: Towards a Critical theory of late-modern temporality. New York, Chichester, West Sussex: University of Columbia Press.
   Google Scholar
• Sahakian, B., & LaBuzetta, J.N. (2013). Bad moves: How decision making goes wrong, and the ethics of smart drugs. Oxford: Oxford University Press..
   Google Scholar
• Schelle, K.J., Faulmüller, N., Caviola, L., & Hewstone, M. (2014). Attitudes toward pharmacological cognitive enhancement - a review. Frontiers in Systems Neuroscience, 8, 53. doi:10.3389/fnsys.2014.00053
   PubMedGoogle Scholar
• Sentintia, W. (2004). Neuroethical considerations: Cognitive liberty and converging technologies for improving human cognition. Annals of the New York Academy of Sciences, 1013, 221–228. doi:10.1196/annals.1305.014
   PubMed Web of Science ®Google Scholar
• Thomson, A. (2001). Critical reasoning in ethics. London: Routhledge.
   Google Scholar
• Vrecko, S. (2013). Just how cognitive is “cognitive enhancement”? On the significance of emotions in university students' experiences with study drugs. AJOB Neuroscience, 4, 4–12. doi:10.1080/21507740.2012.740141
   PubMedGoogle Scholar
• Vrecko, S. (2015). Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a univeristy campus. Social Science and Medicine, 131, 297–304. doi:10.1016/j.socscimed.2014.10.016
   PubMed Web of Science ®Google Scholar
• Weyandt, L. (2009). Nonmedical prescription stimulant use among a sample of college students: Relationship with psychological variables. Journal of Attention Disorders, 13, 3. doi:10.1177/1087054709342212
   PubMed Web of Science ®Google Scholar
• Zohny, H. (2015). The myth of cognitive enhancement drugs. Neuroethics, 8, 257–269. doi:10.1007/s12152-015-9232-9
   Web of Science ®Google Scholar